Skip to content

Ciprofloxacin

Cipro, Otiprio (ciprofloxacin) is a small molecule pharmaceutical. Ciprofloxacin was first approved as Cipro on 1990-12-26. It is used to treat anthrax, bacterial conjunctivitis, bacterial infections, bacterial skin diseases, and bacteroides infections amongst others in the USA. Ciprodex's patents are valid until 2037-11-12 (FDA).
Trade Name Cipro, Otiprio
Common Name Ciprofloxacin
Indication anthrax, bacterial conjunctivitis, bacterial infections, bacterial skin diseases, bacteroides infections, campylobacter infections, cystitis, diarrhea, dysentery, escherichia coli infections, fever, gonorrhea, haemophilus infections, infectious arthritis, intraabdominal infections, klebsiella infections, neutropenia, osteomyelitis, otitis externa, prostatitis, proteus infections, protozoan infections, pseudomonas infections, pyelonephritis, sinusitis, staphylococcal infections, typhoid fever, urinary tract infections
Drug Class Antibacterials (quinolone derivatives)
Ciprofloxacin
Get full access now